Advertisement
Forecasting tool outperforms individual biomarkers
How Cleveland Clinic is contributing to the future of care
Dose and neutrophil-to-lymphocyte ratio are key factors
Study shows encouraging safety results in rare type of adult brain cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel assay identifies women most likely to benefit
Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery
Retired-protein strategy represents new approach to immunization
Multidisciplinary specialists, social workers and palliative care providers are valuable contributors
Studies investigate two potential risk-prediction methods
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Advertisement
Advertisement